TMS Co., Ltd. (4891.T)
JPY 137.0
(-2.14%)
JPY 137.0
(-2.14%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -6.95 Million JPY | -5.37% |
| 2022 | -6.59 Million JPY | -100.38% |
| 2021 | 1.74 Billion JPY | 42772.0% |
| 2020 | -4.08 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -3.24 Million JPY | -60.84% |
| 2024 Q2 | -234 Thousand JPY | 92.78% |
| 2023 Q1 | -1.52 Million JPY | 36.42% |
| 2023 Q4 | -2.01 Million JPY | -13.39% |
| 2023 FY | -6.95 Million JPY | -5.37% |
| 2023 Q2 | -1.63 Million JPY | -6.95% |
| 2023 Q3 | -1.77 Million JPY | -8.88% |
| 2022 Q2 | - JPY | 0.0% |
| 2022 FY | -6.59 Million JPY | -100.38% |
| 2022 Q4 | -2.4 Million JPY | -33.7% |
| 2022 Q3 | -1.79 Million JPY | 0.0% |
| 2021 FY | 1.74 Billion JPY | 42772.0% |
| 2020 FY | -4.08 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 100.369% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | 108.654% |
| GNI Group Ltd. | 22.43 Billion JPY | 100.031% |
| Linical Co., Ltd. | 3.77 Billion JPY | 100.184% |
| Trans Genic Inc. | 2.24 Billion JPY | 100.309% |
| MEDINET Co., Ltd. | 98.25 Million JPY | 107.074% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 100.28% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 100.538% |
| AnGes, Inc. | -3.06 Billion JPY | 99.773% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 96.089% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 100.072% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 101.344% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | 106.264% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 100.479% |
| CanBas Co., Ltd. | -984 Million JPY | 99.294% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | 101.774% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 100.42% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 101.744% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 100.669% |
| PeptiDream Inc. | 17.21 Billion JPY | 100.04% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | 122.709% |
| Ribomic Inc. | -10.5 Million JPY | 33.822% |
| SanBio Company Limited | -14.5 Million JPY | 52.082% |
| Healios K.K. | 108 Million JPY | 106.435% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | -1938.123% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 88.23% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | -359.656% |
| StemRIM | -44.34 Million JPY | 84.329% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 100.218% |
| FunPep Company Limited | -680.28 Million JPY | 98.978% |
| Kringle Pharma, Inc. | 69.25 Million JPY | 110.036% |
| Stella Pharma Corporation | 217.29 Million JPY | 103.198% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | 102.209% |
| Cuorips Inc. | 9.63 Million JPY | 172.163% |
| K Pharma,Inc. | 910 Million JPY | 100.764% |
| Takara Bio Inc. | 25.45 Billion JPY | 100.027% |
| ReproCELL Incorporated | 1.1 Billion JPY | 100.629% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 100.582% |
| StemCell Institute Inc. | 1.57 Billion JPY | 100.441% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 100.417% |
| CellSeed Inc. | 107.15 Million JPY | 106.486% |